Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-25-015196
Filing Date
2025-02-19
Accepted
2025-02-19 16:38:48
Documents
18
Effectiveness Date
2025-02-19

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm256762-1_s3asr.htm S-3ASR 339903
2 EXHIBIT-4.9 tm256762d2_ex4-9.htm EX-4.9 331574
3 EXHIBIT 5.1 tm256762d2_ex5-1.htm EX-5.1 29201
4 EXHIBIT 23.2 tm256762d2_ex23-2.htm EX-23.2 2412
5 EX-FILING FEES tm256762d1_ex-filingfees.htm   iXBRL EX-FILING FEES 35011
6 GRAPHIC tm256762d2_ex5-1img001.jpg GRAPHIC 4924
7 GRAPHIC tm256762d2_ex5-1img002.jpg GRAPHIC 3448
  Complete submission text file 0001104659-25-015196.txt   911950

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT tm256762d1_ex-filingfees_htm.xml XML 12314
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-285059 | Film No.: 25640890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)